Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib.
EN
채용
1:1 문의하기
메인
COMPANY
NEWS
TECHNOLOGY
R&D
QUALITY
SERVICES
암 검사
유전희귀질환 검사
건강검진 검사
산부인과 검사
필수서류
의료인 전용
BLOG
더보기
Use tab to navigate through the menu items.
Log In